58 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
material included in Company Work Product that qualifies as a “work made for hire” under the U.S. Copyright Act is deemed a “work made for hire” created … the Company or any affiliated company and any employee thereof; or (ii) hire any Restricted Person who was employed by the Company or any affiliated
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
, business or collaboration partners or governmental entities; the ability to retain and hire key personnel; potential adverse reactions or changes to business
425
ezfrjx5n2b1nksw4l
30 May 23
Business combination disclosure
4:21pm
8-K
drj47j4
30 May 23
Submission of Matters to a Vote of Security Holders
4:18pm
425
yro jr5mm5rpavmy
22 May 23
Business combination disclosure
7:01am
8-K
wbr47aklma
22 May 23
Other Events
6:59am
8-K
EX-99.1
l35g30w 2cbz9h79r2
12 May 23
Adaptimmune Reports First Quarter Financial Results and Business Update
7:36am
424B3
wtt186fh
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
pvtj1
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
5vptcrhy4eyc870
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.01
fk6pxxji mc5bv
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am